IAIM
VRCA icon

International Assets Investment Management’s Verrica Pharmaceuticals VRCA Stock Holding History

International Assets Investment Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04K Hold
175
– – ﹤0.01% 2198
2026
Q1 		$961 Hold
175
– – ﹤0.01% 2067
2025
Q4 		$1.45K Buy
+175
New +$970 ﹤0.01% 1990

Other funds holding VRCA

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
NECFA
New England Capital Financial Advisors Meriden, Connecticut $418M AUM 16.7% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
VNA
Valley National Advisers Bethlehem, Pennsylvania $900M AUM 31.19% 1-Year Est. Return

International Assets Investment Management's VRCA Position: Q2 2026 in Review

International Assets Investment Management held its Verrica Pharmaceuticals (VRCA) position steady in Q2 2026 at 175 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

International Assets Investment Management first reported a position in VRCA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.45K in Q4 2025. 6 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • International Assets Investment Management held 175 shares of Verrica Pharmaceuticals worth $1.04K as of Q2 2026.
  • International Assets Investment Management left its Verrica Pharmaceuticals share count unchanged in Q2 2026.
  • Verrica Pharmaceuticals made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2198 holding.
  • International Assets Investment Management first reported a position in Verrica Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • International Assets Investment Management's Verrica Pharmaceuticals position peaked at $1.45K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.